Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence.
This funding will allow Diabeloop to accelerate its international commercial deployment in both Europe and the US, and will support the award-winning company’s innovative programs.

Complete press release Diabeloop